| Journal | International journal of environmental research and public health |
| Study Type | Clinical Study |
| Population | Human participants |
Cannabis taxation directly impacts patient access and affordability, particularly for medical users who may face the same tax burden as recreational consumers. Understanding standardized tax rates across states helps clinicians counsel patients on cost considerations when recommending cannabis therapy.
This observational study analyzed retail cannabis data from 12 states with legal recreational markets between 2020-2024, developing standardized excise tax metrics across flower, vaping, and edible product categories. The researchers found mean standardized excise taxes of $32.58/ounce for flower, $180.21/ounce for vaping products, with significant variation across states and product types. The study provides a framework for comparing tax burden across different cannabis products and jurisdictions, though clinical outcomes were not assessed.
“While tax policy feels removed from clinical practice, it directly affects my patients’ access to recommended cannabis products. The dramatically higher tax burden on vaping products versus flower may inadvertently push patients toward smoking, which contradicts harm reduction principles.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- How do cannabis excise tax rates vary between different product categories?
- Why is standardizing cannabis tax rates across states important for public health?
- What clinical implications arise from different tax burdens on cannabis product categories?
- How might cannabis excise tax policies affect patient access to medical cannabis?
- What should healthcare providers consider regarding cannabis taxation when counseling patients?
FAQ
How do cannabis excise tax rates vary between different product categories?
Based on standardized retail price measurements, vaping products carry the highest tax burden at $180.21 per ounce, while flower products have significantly lower taxes at $32.58 per ounce. This variation reflects different state tax structures and the concentrated nature of vaping products compared to traditional flower.
Why is standardizing cannabis tax rates across states important for public health?
Standardized tax metrics enable meaningful cross-state comparisons and strengthen evaluations of how taxation policies influence public health outcomes. Without standardization, the wide variation in tax structures across states makes it difficult to assess the effectiveness of different policy approaches on cannabis use patterns and related health impacts.
What clinical implications arise from different tax burdens on cannabis product categories?
The substantial tax differences between product categories may influence patient product selection and consumption patterns, potentially affecting therapeutic outcomes. Clinicians should be aware that economic factors driven by tax policy may lead patients toward lower-taxed products that may not align with their optimal therapeutic needs.
How might cannabis excise tax policies affect patient access to medical cannabis?
High excise tax rates, particularly on concentrated products like vapes, may create financial barriers to accessing cannabis for medical purposes. This economic burden could disproportionately impact patients with chronic conditions who rely on consistent access to specific cannabis formulations for symptom management.
What should healthcare providers consider regarding cannabis taxation when counseling patients?
Providers should recognize that tax-driven price differences may influence patient product choices and consumption behaviors beyond medical recommendations. Understanding local tax structures can help clinicians better counsel patients on cost-effective treatment options while maintaining therapeutic efficacy.